Risk of Major Adverse Cardiovascular Events in Home Dialysis Compared to In-Center Hemodialysis
IF 8.5
1区 医学
Q1 UROLOGY & NEPHROLOGY
Wisam Bitar, Jaakko Helve, Mikko Haapio, Virpi Rauta, Eero Honkanen, Patrik Finne
求助PDF
{"title":"Risk of Major Adverse Cardiovascular Events in Home Dialysis Compared to In-Center Hemodialysis","authors":"Wisam Bitar, Jaakko Helve, Mikko Haapio, Virpi Rauta, Eero Honkanen, Patrik Finne","doi":"10.2215/cjn.0000000579","DOIUrl":null,"url":null,"abstract":"d continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD) and home hemodialysis (HD) with in-center HD patients. Methods: We included 968 patients who entered dialysis in the Helsinki-Uusimaa healthcare district in Finland from 2004 to 2017, of whom 162 were on CAPD, 229 on APD, 145 on home HD and 432 on in-center HD at day 90 from the start of dialysis. MACE was defined as acute myocardial infarction, stroke, or death due to cardiovascular disease. The cumulative incidence of the first MACE was calculated. Cox regression was used to compare risk of MACE between dialysis modalities with adjustment for potential confounding factors. Results: Of all 968 patients, 195 (20%) experienced a MACE during the entire follow-up and 62 (6%) during the first year of follow-up. The cumulative incidence of first MACE was similar in in-center HD and CAPD patients and higher than that in APD and home HD patients. After adjustment for possible confounders, the hazard ratio (HR) of MACE was 1.22 [95% confidence intervals (CI) 0.73–2.05] for CAPD, 0.86 [95% CI 0.47–1.57] for APD and 0.67 [95% CI 0.30–1.50] for home HD compared to in-center HD. Unexpectedly, compared to in-center HD, PD associated with lower risk of MACE among females (HR 0.37, 95% CI 0.14–0.99) and higher risk among males (HR 1.80, 95% CI 1.11–2.92). Conclusions: In this cohort, the risk of MACE was comparable across in-center and home dialysis modalities. However, the result differed between males and females, which requires further research. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology...","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"19 1","pages":""},"PeriodicalIF":8.5000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Journal of the American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2215/cjn.0000000579","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
d continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD) and home hemodialysis (HD) with in-center HD patients. Methods: We included 968 patients who entered dialysis in the Helsinki-Uusimaa healthcare district in Finland from 2004 to 2017, of whom 162 were on CAPD, 229 on APD, 145 on home HD and 432 on in-center HD at day 90 from the start of dialysis. MACE was defined as acute myocardial infarction, stroke, or death due to cardiovascular disease. The cumulative incidence of the first MACE was calculated. Cox regression was used to compare risk of MACE between dialysis modalities with adjustment for potential confounding factors. Results: Of all 968 patients, 195 (20%) experienced a MACE during the entire follow-up and 62 (6%) during the first year of follow-up. The cumulative incidence of first MACE was similar in in-center HD and CAPD patients and higher than that in APD and home HD patients. After adjustment for possible confounders, the hazard ratio (HR) of MACE was 1.22 [95% confidence intervals (CI) 0.73–2.05] for CAPD, 0.86 [95% CI 0.47–1.57] for APD and 0.67 [95% CI 0.30–1.50] for home HD compared to in-center HD. Unexpectedly, compared to in-center HD, PD associated with lower risk of MACE among females (HR 0.37, 95% CI 0.14–0.99) and higher risk among males (HR 1.80, 95% CI 1.11–2.92). Conclusions: In this cohort, the risk of MACE was comparable across in-center and home dialysis modalities. However, the result differed between males and females, which requires further research. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology...
家庭透析与中心血液透析相比发生主要不良心血管事件的风险
与中心内血液透析(HD)患者进行连续非卧床腹膜透析(CAPD)、自动腹膜透析(APD)和家庭血液透析(HD)。方法:我们纳入了2004年至2017年期间在芬兰赫尔辛基-乌西马医疗保健区进行透析的968名患者,其中162人在开始透析后的第90天进行了CAPD透析,229人进行了APD透析,145人进行了家庭血液透析,432人进行了中心内血液透析。MACE定义为急性心肌梗死、中风或心血管疾病导致的死亡。计算首次 MACE 的累积发生率。在对潜在混杂因素进行调整后,采用 Cox 回归比较不同透析方式的 MACE 风险。结果:在所有968名患者中,195人(20%)在整个随访期间发生过MACE,62人(6%)在随访第一年发生过MACE。中心内 HD 和 CAPD 患者首次 MACE 的累积发生率相似,但高于 APD 和家庭 HD 患者。对可能的混杂因素进行调整后,与中心内 HD 相比,CAPD 的 MACE 危险比 (HR) 为 1.22 [95% 置信区间 (CI) 0.73-2.05],APD 为 0.86 [95% CI 0.47-1.57],家庭 HD 为 0.67 [95% CI 0.30-1.50]。意外的是,与中心内 HD 相比,PD 与女性 MACE 风险较低(HR 0.37,95% CI 0.14-0.99)和男性 MACE 风险较高(HR 1.80,95% CI 1.11-2.92)相关。结论在该队列中,中心内透析和家庭透析的MACE风险相当。但是,男性和女性的结果有所不同,这需要进一步研究。版权所有 © 2024 作者。由 Wolters Kluwer Health, Inc. 代表美国肾脏病学会出版...
本文章由计算机程序翻译,如有差异,请以英文原文为准。
来源期刊
期刊介绍:
The Clinical Journal of the American Society of Nephrology strives to establish itself as the foremost authority in communicating and influencing advances in clinical nephrology by (1) swiftly and effectively disseminating pivotal developments in clinical and translational research in nephrology, encompassing innovations in research methods and care delivery; (2) providing context for these advances in relation to future research directions and patient care; and (3) becoming a key voice on issues with potential implications for the clinical practice of nephrology, particularly within the United States. Original manuscript topics cover a range of areas, including Acid/Base and Electrolyte Disorders, Acute Kidney Injury and ICU Nephrology, Chronic Kidney Disease, Clinical Nephrology, Cystic Kidney Disease, Diabetes and the Kidney, Genetics, Geriatric and Palliative Nephrology, Glomerular and Tubulointerstitial Diseases, Hypertension, Maintenance Dialysis, Mineral Metabolism, Nephrolithiasis, and Transplantation.